NinePointTwo Capital »

Rocket Pharmaceuticals shares owned by NinePointTwo Capital

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by NinePointTwo Capital from 13F filings

Historical chart of NinePointTwo Capital investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by NinePointTwo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by NinePointTwo Capital

Quarter filed Position value Share count Share price at filing
2023-06-30 $237k 12k 19.86
2023-03-31 $204k 12k 17.09

More positions owned by NinePointTwo Capital

Schwab Strategic Tr Us Tips Etf (SCHP)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Ishares Tr Tips Bd Etf (TIP)
Dbx Etf Tr Xtrack Usd High (HYLB)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Ishares Tr Select Divid Etf (DVY)
Apollo Global Mgmt (APO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Apple (AAPL)
Hca Holdings (HCA)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Nxp Semiconductors N V (NXPI)

View all positions for NinePointTwo Capital

Top funds holding Rocket Pharmaceuticals

Rtw Investments
Maverick Capital
BlackRock
Vanguard Group
MPM Oncology Impact Management
Suvretta Capital Management
Millennium Management
Monaco Asset Management SAM
Newtyn Management
D. E. Shaw & Co
Jpmorgan Chase & Co
Geode Capital Management
Citadel Advisors
Two Sigma Advisers
State Street Corporation

View all funds holding Rocket Pharmaceuticals